top of page

State vs Federal: The DEA's Warning to Georgia Over Medical Marijuana Sales


Photo: https://www.foxbusiness.com/ | (Getty / Getty Images)

The situation regarding the sale of medical marijuana in pharmacies in Georgia is complex and has attracted national attention due to the conflicting stances between state law and federal directives.


In Georgia, the state had moved forward with plans to become the first in the nation to allow pharmacies to dispense medical marijuana products. This initiative was part of Georgia's efforts to expand access to medical cannabis for eligible patients. The state's medical marijuana panel, the Georgia Access to Medical Cannabis Commission, oversees the state's medical marijuana industry. The Georgia Board of Pharmacy began accepting applications from independent pharmacies to dispense marijuana products in October, and licenses were issued to 23 independent pharmacies in the state.


However, the U.S. Drug Enforcement Administration (DEA) intervened with a clear warning, stating that dispensing medical marijuana violates federal law. On November 27, 2023, the DEA issued a memorandum to pharmacies, asserting that no pharmacy registered with the DEA can lawfully possess, handle, or dispense marijuana or related products containing more than 0.3% tetrahydrocannabinol (THC), the psychoactive component of cannabis. This stance is based on the federal classification of marijuana as a Schedule I controlled substance under the Controlled Substances Act, which categorizes it as having a high risk of abuse and no accepted medical use.



The conflict arises because, under Georgia state law, eligible patients are allowed to buy low-THC medical marijuana products with up to 5% THC. However, this state authorization clashes with the federal classification of marijuana. The Georgia Access to Medical Cannabis Commission acknowledged the federal directive and noted that it is beyond their ability to intervene in this federal issue.


This situation presents a significant challenge for the state of Georgia. It highlights the complex landscape of marijuana legislation in the United States, where different states have varying laws regarding the use and distribution of medical and recreational marijuana, often in conflict with federal laws.


In summary, while Georgia had plans to pioneer the dispensing of medical marijuana through pharmacies, the DEA's warning represents a major setback in these efforts, emphasizing the ongoing debate and legal complexities surrounding cannabis legislation in the U.S.




News (2).png
News (4).png
Check back soon
Once posts are published, you’ll see them here.
bottom of page